ReNeuron Group plc Stock: price and insider trades · United Kingdom
No insider purchase over the last 90 days. The latest, by Iain Gladstone Ross, was filed 02 Sept 2022.
ReNeuron Group plc: what insiders have been doing
We have very little insider data for ReNeuron Group plc so far: the most recent filing dates from 2 September 2022. With so few records, no pattern can be drawn yet. Source: insider filings from RNS (LSE). Past trades are no guide to future returns.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
- 100,000 shares@ £0.277100.0% of flowLondon Stock Exchange AIM MarketISIN GB00BF5G6K95FCA-NSM:4496456Canonical exit: 1 Dec 2022 (T+90)
1 of 1 declaration
About ReNeuron Group plc
ReNeuron Group plc is a UK-based biopharmaceutical company focused on developing cell therapies for neurodegenerative diseases. It aims to research and commercialize innovative treatments to enhance patients' quality of life.
